Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 189

1.

Overlap of systemic lupus erythematosus and myositis is rare in anti-Ku antibody-positive patients.

Ogawa-Momohara M, Muro Y, Akiyama M.

Ann Rheum Dis. 2019 Oct 11. pii: annrheumdis-2019-216375. doi: 10.1136/annrheumdis-2019-216375. [Epub ahead of print] No abstract available.

PMID:
31604706
2.

Hailey-Hailey disease with oesophageal involvement due to a previously unreported ATP2C1 mutation.

Kono M, Kodera M, Inasaka Y, Hasegawa I, Muro Y, Nakazawa Y, Ogi T, Akiyama M.

Eur J Dermatol. 2019 Aug 30. doi: 10.1684/ejd.2019.3507. [Epub ahead of print] No abstract available.

PMID:
31475910
3.

Clinical characteristics of anti-Ro52α and anti-Ro52β antibodies in dermatomyositis/polymyositis.

Ogawa-Momohara M, Muro Y, Mitsuma T, Katayama M, Yanaba K, Nara M, Kakeda M, Akiyama M.

J Dermatol Sci. 2019 Oct;96(1):50-52. doi: 10.1016/j.jdermsci.2019.08.002. Epub 2019 Aug 12. No abstract available.

PMID:
31444014
4.

Clinical features of patients with anti-melanoma differentiation-associated gene-5 antibody-positive dermatomyositis complicated by spontaneous pneumomediastinum.

Yamaguchi K, Yamaguchi A, Itai M, Kashiwagi C, Takehara K, Aoki S, Sawada Y, Taguchi K, Umetsu K, Oshima K, Uchida M, Takemura M, Hara K, Motegi SI, Muro Y, Nakasatomi M, Sakairi T, Hiromura K, Kurabayashi M, Maeno T.

Clin Rheumatol. 2019 Aug 16. doi: 10.1007/s10067-019-04729-5. [Epub ahead of print]

PMID:
31420814
5.

Remodelling of calcinosis cutis in a patient with scleroderma overlap syndrome.

Dittmer MR, Ogawa-Momohara M, Muro Y, Kono M, Akiyama M.

J Eur Acad Dermatol Venereol. 2019 Aug 13. doi: 10.1111/jdv.15864. [Epub ahead of print] No abstract available.

PMID:
31407385
6.

Antiphospholipid antibody-positive Sjögren's syndrome with leg ulcers.

Ota S, Muro Y, Kono M, Goto N, Akiyama M.

J Dermatol. 2019 Jul 19. doi: 10.1111/1346-8138.15014. [Epub ahead of print] No abstract available.

PMID:
31321801
7.

Drug-induced acute eosinophilic pneumonia due to hydroxychloroquine in a chilblain lupus patient.

Ishiguro Y, Muro Y, Murase C, Takeichi T, Kono M, Adachi R, Takahashi K, Akiyama M.

J Dermatol. 2019 Oct;46(10):e356-e357. doi: 10.1111/1346-8138.14905. Epub 2019 May 3. No abstract available.

PMID:
31050015
8.

Vasculitic neuropathy with anti-phosphatidylserine/prothrombin complex antibody.

Ando T, Iijima M, Fukami Y, Nishi R, Ikeda S, Yokoi S, Kawagashira Y, Koike H, Muro Y, Katsuno M.

Muscle Nerve. 2019 Jun;59(6):E44-E46. doi: 10.1002/mus.26458. Epub 2019 Mar 14. No abstract available.

PMID:
30810234
9.

Unilateral case of multiple minute digitate hyperkeratosis.

Okochi S, Kono M, Takama H, Takeichi T, Muro Y, Akiyama M.

J Dermatol. 2019 Jun;46(6):e210-e211. doi: 10.1111/1346-8138.14777. Epub 2019 Jan 28. No abstract available.

PMID:
30690772
10.

A Japanese Case of Galli-Galli Disease due to a Previously Unreported POGLUT1 Mutation.

Kono M, Sawada M, Nakazawa Y, Ogi T, Muro Y, Akiyama M.

Acta Derm Venereol. 2019 Apr 1;99(4):458-459. doi: 10.2340/00015555-3119. No abstract available.

11.

Treatment consensus for management of polymyositis and dermatomyositis among rheumatologists, neurologists and dermatologists.

Kohsaka H, Mimori T, Kanda T, Shimizu J, Sunada Y, Fujimoto M, Kawaguchi Y, Jinnin M, Muro Y, Ishihara S, Tomimitsu H, Ohta A, Sumida T.

Mod Rheumatol. 2019 Jan;29(1):1-19. doi: 10.1080/14397595.2018.1521185. Epub 2018 Dec 19.

PMID:
30565491
12.

Treatment consensus for management of polymyositis and dermatomyositis among rheumatologists, neurologists and dermatologists.

Kohsaka H, Mimori T, Kanda T, Shimizu J, Sunada Y, Fujimoto M, Kawaguchi Y, Jinnin M, Muro Y, Ishihara S, Tomimitsu H, Ohta A, Sumida T.

J Dermatol. 2019 Jan;46(1):e1-e18. doi: 10.1111/1346-8138.14604. Epub 2018 Dec 18.

PMID:
30562845
13.

Prognosis of dysphagia in dermatomyositis.

Ogawa-Momohara M, Muro Y, Kono M, Akiyama M.

Clin Exp Rheumatol. 2019 Jan-Feb;37(1):165. Epub 2018 Nov 19. No abstract available.

14.

Acrodermatitis continua of Hallopeau with dense infiltration of IgG4-positive cells in the lesional dermis.

Ogawa-Momohara M, Muro Y, Nakaguro M, Takeichi T, Kono M, Akiyama M.

Br J Dermatol. 2019 Apr;180(4):941-942. doi: 10.1111/bjd.17405. Epub 2018 Dec 27. No abstract available.

PMID:
30411319
15.

Dyschromatosis symmetrica hereditaria may be successfully controlled by topical sunscreen.

Kono M, Okamoto T, Takeichi T, Muro Y, Akiyama M.

Eur J Dermatol. 2018 Dec 1;28(6):840-841. doi: 10.1684/ejd.2018.3415. No abstract available.

PMID:
30378542
16.

Hyaline vascular-type unicentric Castleman disease presenting as a subcutaneous nodule in a child.

Hanamura T, Kono M, Yokota K, Takeichi T, Kohno K, Nakamura S, Mitsuma T, Nakajima K, Muro Y, Akiyama M.

J Dermatol. 2019 Mar;46(3):e97-e99. doi: 10.1111/1346-8138.14626. Epub 2018 Aug 29. No abstract available.

PMID:
30156317
17.

Clinical subsets of juvenile dermatomyositis classified by myositis-specific autoantibodies: Experience at a single center in Japan.

Iwata N, Nakaseko H, Kohagura T, Yasuoka R, Abe N, Kawabe S, Sugiura S, Muro Y.

Mod Rheumatol. 2019 Sep;29(5):802-807. doi: 10.1080/14397595.2018.1511025. Epub 2018 Sep 10.

PMID:
30092736
18.

Anti-SAE Antibody-Positive Dermatomyositis in a Japanese Patient: A Case Report and Review of the Literature.

Matsuo H, Yanaba K, Umezawa Y, Nakagawa H, Muro Y.

J Clin Rheumatol. 2019 Oct;25(7):e115-e116. doi: 10.1097/RHU.0000000000000683. No abstract available.

PMID:
30074913
19.

Simple and low-cost tabletop NMR system for chemical-shift-resolution spectra measurements.

Hibino Y, Sugahara K, Muro Y, Tanaka H, Sato T, Kondo Y.

J Magn Reson. 2018 Sep;294:128-132. doi: 10.1016/j.jmr.2018.07.003. Epub 2018 Jul 7.

PMID:
30036813
20.

Impact of relative dose intensity in gemcitabine-cisplatin chemotherapy for metastatic urothelial carcinoma.

Kohei N, Sugiyama K, Chihara I, Muro Y, Imamura M, Nishio Y, Yoshimura K.

SAGE Open Med. 2018 Jun 26;6:2050312118783011. doi: 10.1177/2050312118783011. eCollection 2018.

21.

Eosinophilia and systemic symptoms with transient ageusia: a drug reaction caused by zonisamide.

Adachi R, Kono M, Takeichi T, Muro Y, Akiyama M.

Eur J Dermatol. 2018 Aug 1;28(4):523-524. doi: 10.1684/ejd.2018.3313. No abstract available.

PMID:
29976544
22.

Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies.

Yamaguchi K, Yamaguchi A, Kashiwagi C, Sawada Y, Taguchi K, Umetsu K, Oshima K, Uchida M, Suzuki M, Kono S, Takemura M, Masubuchi H, Kitahara S, Hara K, Maeno T, Motegi SI, Muro Y, Sakairi T, Hisada T, Kurabayashi M.

Respir Med. 2018 Jul;140:1-5. doi: 10.1016/j.rmed.2018.05.010. Epub 2018 May 22.

PMID:
29957268
23.

Analysis of genotype/phenotype correlations in Japanese patients with dyschromatosis symmetrica hereditaria.

Kobayashi T, Kono M, Suganuma M, Akita H, Takai A, Tsutsui K, Inasaka Y, Takeichi T, Muro Y, Akiyama M.

Nagoya J Med Sci. 2018 May;80(2):267-277. doi: 10.18999/nagjms.80.2.267.

24.

Dyschromatosis symmetrica hereditaria with chilblains due to a novel two-amino-acid deletion in the double-stranded RNA-binding domain of ADAR1.

Kono M, Suganuma M, Shimada T, Ishikura Y, Watanabe S, Takeichi T, Muro Y, Akiyama M.

J Eur Acad Dermatol Venereol. 2018 Oct;32(10):e394-e396. doi: 10.1111/jdv.15076. Epub 2018 Jun 11. No abstract available.

PMID:
29775506
25.

Strong correlation between cancer progression and anti-transcription intermediary factor 1γ antibodies in dermatomyositis patients.

Ogawa-Momohara M, Muro Y, Mitsuma T, Katayama M, Yanaba K, Nara M, Kakeda M, Kono M, Akiyama M.

Clin Exp Rheumatol. 2018 Nov-Dec;36(6):990-995. Epub 2018 May 8.

26.

Mild Hailey-Hailey disease cases with aberrant splicing variants of ATP2C1 successfully controlled with excimer light.

Kono M, Niizawa M, Takeichi T, Muro Y, Akiyama M.

J Eur Acad Dermatol Venereol. 2018 Nov;32(11):e413-e416. doi: 10.1111/jdv.15004. Epub 2018 May 18. No abstract available.

PMID:
29705999
27.

Fasciitis as a disease manifestation in immune-mediated necrotizing myopathy with anti-signal recognition particle antibodies: a case report of two cases.

Yoshida K, Ito H, Ukichi T, Matsushita T, Furuya K, Noda K, Muro Y, Kurosaka D.

Rheumatol Adv Pract. 2018 Apr 25;2(1):rky015. doi: 10.1093/rap/rky015. eCollection 2018. No abstract available.

28.

Bilateral striatal necrosis and dyschromatosis symmetrica hereditaria: A-I editing efficiency of ADAR1 mutants and phenotype expression.

Kono M, Suganuma M, Dutta A, Ghosh SK, Takeichi T, Muro Y, Akiyama M.

Br J Dermatol. 2018 Aug;179(2):509-511. doi: 10.1111/bjd.16610. Epub 2018 May 29. No abstract available.

PMID:
29603717
29.

Intramuscular haemorrhage in a patient with dermatomyositis and anti-TIF1γ antibodies.

Adachi R, Muro Y, Kono M, Akiyama M.

Eur J Dermatol. 2018 Feb 1;28(1):116-118. doi: 10.1684/ejd.2017.3168. No abstract available.

PMID:
29521630
30.

Filaggrin gene mutations may influence the persistence of food allergies in Japanese primary school children.

Kono M, Akiyama M, Inoue Y, Nomura T, Hata A, Okamoto Y, Takeichi T, Muro Y, McLean WHI, Shimizu H, Sugiura K, Suzuki Y, Shimojo N.

Br J Dermatol. 2018 Jul;179(1):190-191. doi: 10.1111/bjd.16375. Epub 2018 May 18. No abstract available.

PMID:
29369340
31.

Anti-transcription intermediary factor 1γ antibody titer correlates with clinical symptoms in a patient with recurrent dermatomyositis associated with ovarian cancer.

Teraishi M, Nakajima K, Ishimoto T, Yamamoto M, Maeda N, Muro Y, Sano S.

Int J Rheum Dis. 2018 Apr;21(4):900-902. doi: 10.1111/1756-185X.13264. Epub 2018 Jan 17. No abstract available.

PMID:
29341447
32.

Splicing variant of WDFY4 augments MDA5 signalling and the risk of clinically amyopathic dermatomyositis.

Kochi Y, Kamatani Y, Kondo Y, Suzuki A, Kawakami E, Hiwa R, Momozawa Y, Fujimoto M, Jinnin M, Tanaka Y, Kanda T, Cooper RG, Chinoy H, Rothwell S, Lamb JA, Vencovský J, Mann H, Ohmura K, Myouzen K, Ishigaki K, Nakashima R, Hosono Y, Tsuboi H, Kawasumi H, Iwasaki Y, Kajiyama H, Horita T, Ogawa-Momohara M, Takamura A, Tsunoda S, Shimizu J, Fujio K, Amano H, Mimori A, Kawakami A, Umehara H, Takeuchi T, Sano H, Muro Y, Atsumi T, Mimura T, Kawaguchi Y, Mimori T, Takahashi A, Kubo M, Kohsaka H, Sumida T, Yamamoto K.

Ann Rheum Dis. 2018 Apr;77(4):602-611. doi: 10.1136/annrheumdis-2017-212149. Epub 2018 Jan 13.

PMID:
29331962
33.

Pansclerotic morphea associated with hypohidrosis and anti-M3 muscarinic acetylcholine receptor antibodies.

Fujita-Tanaka H, Ogawa Y, Muro Y, Ogawa-Momohara M, Asashima H, Tsuboi H, Sumida T, Akiyama M.

Br J Dermatol. 2018 Mar;178(3):e210-e211. doi: 10.1111/bjd.16021. Epub 2018 Jan 22. No abstract available.

PMID:
28977673
34.

Prevalence of anti-NT5C1A antibodies in Japanese patients with autoimmune rheumatic diseases in comparison with other patient cohorts.

Muro Y, Nakanishi H, Katsuno M, Kono M, Akiyama M.

Clin Chim Acta. 2017 Sep;472:1-4. doi: 10.1016/j.cca.2017.07.002. Epub 2017 Jul 4.

PMID:
28687351
35.

Autoantibodies to Su/Argonaute 2 in Japanese patients with inflammatory myopathy.

Ogawa-Momohara M, Muro Y, Satoh M, Akiyama M.

Clin Chim Acta. 2017 Aug;471:304-307. doi: 10.1016/j.cca.2017.06.022. Epub 2017 Jun 30.

PMID:
28673815
36.

Hailey-Hailey disease due to ATP2C1 splice site mutation, successfully treated with minocycline hydrochloride.

Kono M, Niizawa M, Takeichi T, Muro Y, Akiyama M.

J Eur Acad Dermatol Venereol. 2018 Jan;32(1):e19-e20. doi: 10.1111/jdv.14439. Epub 2017 Jul 20. No abstract available.

PMID:
28653466
37.

A Child with Epidermolytic Ichthyosis from a Parent with Epidermolytic Nevus: Risk Evaluation of Transmission from Mosaic to Germline.

Kono M, Suga Y, Akashi T, Ito Y, Takeichi T, Muro Y, Akiyama M.

J Invest Dermatol. 2017 Sep;137(9):2024-2026. doi: 10.1016/j.jid.2017.04.036. Epub 2017 May 19. No abstract available.

38.

Image Gallery: Palmoplantar hyperkeratosis in dermatomyositis with anti-PM/Scl antibodies.

Taki T, Muro Y, Ogawa Y, Akiyama M.

Br J Dermatol. 2017 May;176(5):e94. doi: 10.1111/bjd.15371. No abstract available.

PMID:
28504398
39.

Phosphorylated signal transducer and activator of transcription 3 in the epidermis in adult-onset Still's disease.

Takeichi T, Watanabe N, Muro Y, Teshigawara S, Sato M, Ban N, Akiyama M.

J Dermatol. 2017 Oct;44(10):1172-1175. doi: 10.1111/1346-8138.13888. Epub 2017 May 4.

PMID:
28470759
40.

Anti-dense Fine Speckled 70 Autoantibodies in Japanese Children with Dermatomyositis, Localized Scleroderma, and Idiopathic Arthritis with Iridocyclitis.

Muro Y, Iwata N, Tanaka Y, Kodera M, Kono M, Akiyama M.

J Rheumatol. 2017 May;44(5):711-712. doi: 10.3899/jrheum.161409. No abstract available.

PMID:
28461535
41.

Anti-PM/Scl antibody-positive dermatomyositis in a Japanese patient: a case report and review of the literature.

Kohara A, Yanaba K, Muro Y, Ito H, Nakagawa H, Noda K, Kurosaka D.

Int J Rheum Dis. 2017 Dec;20(12):2186-2189. doi: 10.1111/1756-185X.13019. Epub 2017 Feb 10. No abstract available.

PMID:
28185425
42.

Juvenile dermatomyositis positive for anti-DNA mismatch repair enzyme antibodies.

Kubo N, Yanaba K, Kikuchi S, Fukuchi O, Nakagawa H, Namba H, Muro Y.

Eur J Dermatol. 2017 Feb 1;27(1):97-99. doi: 10.1684/ejd.2016.2823. No abstract available.

PMID:
28073708
43.

A case of antisynthetase syndrome with elevated serum CA19-9 associated with interstitial lung disease.

Minami S, Nakanishi T, Tanaka T, Muro Y, Fujimoto N.

Eur J Dermatol. 2017 Feb 1;27(1):78-80. doi: 10.1684/ejd.2016.2890. No abstract available.

PMID:
27777184
44.

Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study.

Musset L, Allenbach Y, Benveniste O, Boyer O, Bossuyt X, Bentow C, Phillips J, Mammen A, Van Damme P, Westhovens R, Ghirardello A, Doria A, Choi MY, Fritzler MJ, Schmeling H, Muro Y, García-De La Torre I, Ortiz-Villalvazo MA, Bizzaro N, Infantino M, Imbastaro T, Peng Q, Wang G, Vencovský J, Klein M, Krystufkova O, Franceschini F, Fredi M, Hue S, Belmondo T, Danko K, Mahler M.

Autoimmun Rev. 2016 Oct;15(10):983-93. doi: 10.1016/j.autrev.2016.07.023. Epub 2016 Aug 1. Review.

PMID:
27491568
45.

Ortner's syndrome caused by pulmonary arterial hypertension associated with mixed connective tissue disease.

Ogawa-Momohara M, Muro Y, Hirashiki A, Fujimoto Y, Kondo T, Akiyama M.

Clin Exp Rheumatol. 2016 Nov-Dec;34(6):1125. Epub 2016 Jul 26. No abstract available.

PMID:
27463267
46.

A patient with Parkinson's disease and dermatomyositis with serum anti-transcriptional intermediary factor 1-γ antibody.

Murase C, Muro Y, Nakanishi H, Katsuno M, Akiyama M.

Eur J Dermatol. 2016 Dec 1;26(6):617-618. doi: 10.1684/ejd.2016.2857. No abstract available.

PMID:
27457413
47.

Anti-TIF1-γ-positive young adult dermatomyositis with germ cell tumour.

Taki E, Shimizu M, Soeda Y, Shirai M, Muro Y.

Eur J Dermatol. 2016 Dec 1;26(6):623-624. doi: 10.1684/ejd.2016.2856. No abstract available.

PMID:
27457276
48.

HMGCR antibody-associated myopathy as a paraneoplastic manifestation of esophageal carcinoma.

Tsujikawa K, Hara K, Muro Y, Nakanishi H, Niwa Y, Koike M, Noda S, Riku Y, Sahashi K, Atsuta N, Ito M, Shimoyama Y, Akiyama M, Katsuno M.

Neurology. 2016 Aug 23;87(8):841-3. doi: 10.1212/WNL.0000000000003006. Epub 2016 Jul 22. No abstract available.

49.

Antisynthetase syndrome: Pulmonary computed tomography findings of adult patients with antibodies to aminoacyl-tRNA synthetases.

Waseda Y, Johkoh T, Egashira R, Sumikawa H, Saeki K, Watanabe S, Matsunuma R, Takato H, Ichikawa Y, Hamaguchi Y, Shiraki A, Muro Y, Yasui M, Prosch H, Herold C, Kasahara K.

Eur J Radiol. 2016 Aug;85(8):1421-6. doi: 10.1016/j.ejrad.2016.05.012. Epub 2016 May 24.

50.

The Behavior and Acrosomal Status of Mouse Spermatozoa In Vitro, and Within the Oviduct During Fertilization after Natural Mating.

Hino T, Muro Y, Tamura-Nakano M, Okabe M, Tateno H, Yanagimachi R.

Biol Reprod. 2016 Sep;95(3):50. doi: 10.1095/biolreprod.116.140400. Epub 2016 Jul 14.

PMID:
27417908

Supplemental Content

Support Center